Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can’t be surgically removed.
The platform allows for greater precision and thoroughness in cancer treatment.
Here’s how it works:
Nanoparticles tightly loaded with a dye compound are administered systemically – injected intravenously or into the peritoneum, the abdominal cavity. When they reach the tumor site, the tumor’s intracellular environment effectively flips the switch on the compound’s fluorescence.
That enables detection by a near infrared (NIR) imaging system that helps surgeons know in real time what needs to be removed.
Any glowing areas that can’t be cut out are given phototherapy – irradiated with a near infrared laser, which causes the nanoparticles to heat up and kill the residual cancer cells.
The findings by researchers in the OSU/OHSU College of Pharmacy and OSU College of Veterinary Medicine were published this month in Theranostics.
The nanomedicine platform consists of silicon naphthalocyanine (SiNc) densely packed in biodegradable PEG-PCL nanoparticles. Because the SiNc is engineered to be non-fluorescent initially – until the tumor activates the fluorescence by loosening the packing – it doesn’t cause any non-cancerous tissue to glow.
Corresponding authors Olena Taratula and Oleh Taratula of the Department of Pharmaceutical Sciences and their collaborators evaluated the platform in vitro and in two different mouse models, including one that mimicked ovarian intraperitoneal metastasis.
The research team operated on the mice using real-time imaging, which showed that the new nanoparticles are compatible with a standard, FDA-approved imaging system. The efficacy of the phototherapy was also demonstrated in vivo.
“The nanoplatform system is quite simple but quite effective,” Olena Taratula said.
Subsequent laboratory testing of the platform will include rats, she said, followed by testing on dogs that are already scheduled for cancer surgeries at the College of Veterinary Medicine.
“They’re going to do surgery on those dogs anyway, and they can use our nanomedicine platform as an additional tool to see if they can identify the cancer cells,” Taratula said.
The Latest on: Flourescent nanomedicine
- New Fluorescent Tags Developed to Track Cause of Alzheimer’son September 26, 2019 at 8:03 am
To overcome this serious limitation, chemists at Rice University have now synthesized fluorescent ruthenium-based tags that attach themselves to oligomeric amyloid beta peptides during their formation ...
- Liposomal Nanomedicine for Breast Cancer Therapyon September 12, 2019 at 5:00 pm
CMV-SPORT-β-gal Haloperidol Sigma receptors Haloperidol-conjugated targeted lipoplex showed tenfold higher reporter gene expression in MCF-7 cells in comparison to control lipoplex  p53 Estradiol ...
- Multicolor Activated Fluorescent Dyes Thanks to Single Atom Replacementon September 12, 2019 at 8:49 am
Fluorescent dyes have transformed biomedical science. The Nobel Prize in Chemistry for 2008, for example, was given for the discovery and development of green fluorescent protein, GFP. Ever since GFP ...
- New optical imaging system could be deployed to find tiny tumorson March 7, 2019 at 6:37 am
Researchers have developed a near-infrared fluorescent optical imaging system that could ... the Marble Center for Cancer Nanomedicine, the Koch Institute Support (core) Grant from the National Cancer ...
- Nanomedicine expert joins Rice faculty: Gang Bao combines genetic, nano and imaging techniques to fight diseaseon December 16, 2018 at 4:00 pm
Among their ongoing projects, lab members are working on targeted genome modification using engineered nucleases, the development of magnetic nanoparticles for use as contrast agents and for ablation ...
- MSK-Cornell Center for Translation of Cancer Nanomedicineon March 6, 2018 at 8:33 am
The goal of the MSK-Cornell Center for Translation of Cancer Nanomedicine (MC 2 TCN) is to advance, translate, and disseminate a suite of ultrasmall (
- Fluorescent Nanomedicine Guiding Tumor Removalon February 1, 2018 at 4:00 pm
A nanomedicine platform has been developed for use with the treatment of cancer that will help doctors to know which tissue to cut away for removal as well as kill any malignant cells which are not ...
- Fluorescent nanomedicine can guide tumor removal, kill remaining cancer cellson December 20, 2017 at 4:00 pm
The nanomedicine platform consists of silicon naphthalocyanine (SiNc) densely packed in biodegradable PEG-PCL nanoparticles. Because the SiNc is engineered to be non-fluorescent initially - until the ...
- Fluorescent nanomedicine can guide tumor removal, kill remaining cancer cellson December 19, 2017 at 4:00 pm
Scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed. The platform ...
via Google News and Bing News